https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2023-11026&r=1
A Study to find the Highest Dose of Imetelstat in Combination with Fludarabine and Cytarabine for...
A Study to find the Highest Dose of Imetelstat in Combination with Fludarabine and Cytarabine for Patients with AML, MDS or JMML That Has Come Back or Does Not...
https://www.aacr.org/patients-caregivers/progress-against-cancer/imetelstat-approved-for-certain-myelodysplastic-syndromes/
Imetelstat Approved for Certain Myelodysplastic Syndromes | Research | AACR
Jun 28, 2024 - The first-in-class targeted therapy imetelstat inhibits telomerase, a cancer-promoting protein, to treat certain myelodysplastic syndromes.
for certainmyelodysplastic syndromesimetelstatapprovedresearch
https://pmc.ncbi.nlm.nih.gov/articles/PMC11623864/
Imetelstat (Rytelo): a promising treatment for adults with lower-risk MDS and transfusion-dependent...
https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-imetelstat-low-intermediate-1-risk-myelodysplastic-syndromes-transfusion-dependent
FDA approves imetelstat for low- to intermediate-1 risk myelodysplastic syndromes with...
On June 6, 2024, the Food and Drug Administration approved imetelstat (Rytelo, Geron Corporation), an oligonucleotide telomerase inhibitor, for adults with...
https://www.jnj.com/media-center/press-releases/janssen-elects-not-to-continue-agreement-with-geron-for-imetelstat
Janssen Elects Not to Continue Agreement with Geron for Imetelstat
not tojanssencontinueagreementgeron
https://www.mayo.edu/research/clinical-trials/cls-20203536?&p=1
Study To Evaluate Imetelstat (JNJ-63935937) In Subjects With International Prognostic Scoring...